TY - JOUR
T1 - Blood levels of reduced and oxidized glutathione in malignant and non-malignant human colorectal lesions
AU - Boisio, Maria Luisa
AU - Merlo, Franco
AU - Martines, Hugo
AU - Esposito, Mauro
PY - 1990
Y1 - 1990
N2 - Glutathione blood levels were determined in colorectal cancer patients (n = 10), patients with adenomatous colorectal polyps (n = 8), and healthy subjects (control group; n = 10). Mean GSH level (μg/ml) was significantly higher in cancer patients [515.4 ± 76.1 (S.D.)] than in those with polyps [407.7 ± 90.5 (S.D.), P <0.05] and the control group [360.9 ± 67.9 (S.D.), P <0.001]. Statistically significant lower GSSG blood levels were observed in cancer patients when compared to the other groups. The highest mean blood GSH/GSSG ratio (log transformed) was observed in cancer patients [2.17 ± 0.108 (S.D.)] and the lowest in healthy subjects [1.88 ± 0.032 (S.D.)]. All between-group differences in the GSH/GSSG ratio were statistically significant. These findings suggest that glutathione blood levels as well as GSH/GSSG ratio may have applicability as a guide for following the activity of colorectal diseases.
AB - Glutathione blood levels were determined in colorectal cancer patients (n = 10), patients with adenomatous colorectal polyps (n = 8), and healthy subjects (control group; n = 10). Mean GSH level (μg/ml) was significantly higher in cancer patients [515.4 ± 76.1 (S.D.)] than in those with polyps [407.7 ± 90.5 (S.D.), P <0.05] and the control group [360.9 ± 67.9 (S.D.), P <0.001]. Statistically significant lower GSSG blood levels were observed in cancer patients when compared to the other groups. The highest mean blood GSH/GSSG ratio (log transformed) was observed in cancer patients [2.17 ± 0.108 (S.D.)] and the lowest in healthy subjects [1.88 ± 0.032 (S.D.)]. All between-group differences in the GSH/GSSG ratio were statistically significant. These findings suggest that glutathione blood levels as well as GSH/GSSG ratio may have applicability as a guide for following the activity of colorectal diseases.
UR - http://www.scopus.com/inward/record.url?scp=0025343681&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025343681&partnerID=8YFLogxK
U2 - 10.1016/0277-5379(90)90288-5
DO - 10.1016/0277-5379(90)90288-5
M3 - Article
C2 - 2138911
AN - SCOPUS:0025343681
VL - 26
SP - 89
EP - 91
JO - European Journal of Cancer
JF - European Journal of Cancer
SN - 0959-8049
IS - 2
ER -